Down more than 52% over the past 52 weeks, could Canadian marijuana giant Aurora Cannabis (ACB) go to… zero? One analyst thinks so.
Near the end of November 2019 Aurora Cannabis (ACB) found it would no longer be able to sell medical cannabis to the German …
Even prior to the horrible September quarterly report, analysts were questioning the cash position of Aurora Cannabis (ACB). A big part of the …
Anybody following the Canadian cannabis sector shouldn’t be surprised by the weak quarterly results from Aurora Cannabis (ACB). The cannabis supply flood killed …
With Aurora Cannabis (ACB) ready to report first quarter results after the closing bell on Thursday, November 14th, the question arises as to …
The latest Health Canada stats continue to show the Canadian cannabis market is flooded with supply while most companies are set to further …
Aurora Cannabis (ACB) is well-positioned for the inevitable rebound in the cannabis sector, as it ramps up production capacity, boosts its GMP-compliant output, …
As the sell-off in the cannabis sector continues, questions on the long-term performance of Aurora Cannabis (ACB) have risen to the point the …
When there’s blood in the streets, all the naysayers come out and focus primarily on things that theoretically could go wrong with a …
Analysts identified the biggest risk to the Aurora Cannabis (ACB) story as the company aggressively spending the business towards a liquidity problem. The …
